71 related articles for article (PubMed ID: 22070535)
41. Malnutrition, infection and arteriovenous fistula failure: is there a link?
Gagliardi GM; Rossi S; Condino F; Mancuso D; Greco F; Tenuta R; Savino O; Bonofiglio R; Domma F; Latorre G
J Vasc Access; 2011; 12(1):57-62. PubMed ID: 21038306
[TBL] [Abstract][Full Text] [Related]
42. [The acquired overt cytomegalovirus infection (primary form and reactivation) in adult immune safety patients].
Zhukova LI; Kovalevskaia OI; Lebedev VV; Gorodin VN; Eremina GA
Klin Lab Diagn; 2014 Aug; 59(8):48-52. PubMed ID: 25552054
[TBL] [Abstract][Full Text] [Related]
43. Pustular psoriasis precipitated by cytomegalovirus infection.
Yoneda K; Matsuoka-Shirahige Y; Demitsu T; Kubota Y
Br J Dermatol; 2012 Nov; 167(5):1186-9. PubMed ID: 22564254
[No Abstract] [Full Text] [Related]
44. Impairment of cytomegalovirus and host balance in elderly subjects.
Musiani M; Zerbini M; Zauli D; Cometti G; La Placa M
J Clin Pathol; 1988 Jul; 41(7):722-5. PubMed ID: 2842379
[TBL] [Abstract][Full Text] [Related]
45. Antibody responses to synthetic peptides from cytomegalovirus phosphoprotein 150.
Sundqvist VA; Xu W; Wahren B
J Clin Microbiol; 1992 Oct; 30(10):2735-9. PubMed ID: 1328283
[TBL] [Abstract][Full Text] [Related]
46. Cytomegalovirus pericarditis: a case series and review of the literature.
Campbell PT; Li JS; Wall TC; O'Connor CM; Van Trigt P; Kenney RT; Melhus O; Corey GR
Am J Med Sci; 1995 Apr; 309(4):229-34. PubMed ID: 7900747
[TBL] [Abstract][Full Text] [Related]
47. Serum epidemiological trial on the prevalence of the anti-cytomegalovirus antibodies in patients under substitutive treatment with hemodialysis and CAPD.
Spisni C; Stingone A; Di Vito R; Rondinella I; D'Amario C; Tucci E; Caravelli L; D'Angelo B; Cerasoli P
Nephron; 1992; 61(3):373-4. PubMed ID: 1323796
[TBL] [Abstract][Full Text] [Related]
48. Modulation of the Host Environment by Human Cytomegalovirus with Viral Interleukin 10 in Peripheral Blood.
Young VP; Mariano MC; Tu CC; Allaire KM; Avdic S; Slobedman B; Spencer JV
J Infect Dis; 2017 Mar; 215(6):874-882. PubMed ID: 28453840
[TBL] [Abstract][Full Text] [Related]
49. The significance of cytomegalovirus infection over the clinical course of adult T-cell leukemia/lymphoma.
Fujiwara H; Eizuru Y; Matsumoto T; Kukita T; Imaizumi R; Kawada H; Ohtsubo H; Matsushita K; Arima N; Tei C
Microbiol Immunol; 2001; 45(1):97-100. PubMed ID: 11270615
[TBL] [Abstract][Full Text] [Related]
50. Life Course Socioeconomic Disadvantage and the Aging Immune System: Findings From the Health and Retirement Study.
Noppert GA; Stebbins RC; Dowd JB; Hummer RA; Aiello AE
J Gerontol B Psychol Sci Soc Sci; 2021 Jun; 76(6):1195-1205. PubMed ID: 32880643
[TBL] [Abstract][Full Text] [Related]
51. [THE SELECTION OF ANTIGENS FOR DETECTING OF IMMUNOGLOBULIN G TO CYTOMEGALOVIRUS ON THE BASIS OF FOSFAN TECHNOLOGY].
Nikitina AV; Pomelova VG; Sokolova MV; Osin NS; Mardanly SG
Klin Lab Diagn; 2015 Oct; 60(10):36-9. PubMed ID: 26841671
[TBL] [Abstract][Full Text] [Related]
52. [Cytomegalovirus antibodies in patients and personnel of a hemodialysis unit].
Szepietowski T; Adamiec R; Imbs D
Pol Arch Med Wewn; 1983 Sep; 70(3):101-10. PubMed ID: 6318193
[No Abstract] [Full Text] [Related]
53. Letter: Protection of cytomegalovirus-infected cells by IgG antibody.
Diosi P; Herzog G
Br Med J; 1973 Sep; 3(5881):638. PubMed ID: 4356872
[No Abstract] [Full Text] [Related]
54. Predictors for failure to mature of autogenous arteriovenous fistulae: Alor Setar experience.
Najmi W; Tong LH; Nallusamy M; Musa KI
Med J Malaysia; 2012 Apr; 67(2):165-8. PubMed ID: 22822636
[No Abstract] [Full Text] [Related]
55. Editorial introduction for Seminars in Immunopathology special issue on "immune modulation, properties and models of CMV".
Goldberger T; Mandelboim O
Semin Immunopathol; 2014 Nov; 36(6):611-3. PubMed ID: 25315348
[No Abstract] [Full Text] [Related]
56. Atherosclerosis: infection-induced involvement of mitochondrial chaperonins.
Stöllberger C; Finsterer J
Lancet; 2003 Dec; 362(9400):1949-50. PubMed ID: 14683650
[No Abstract] [Full Text] [Related]
57. Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions.
Bachelet T; Couzi L; Pitard V; Sicard X; Rigothier C; Lepreux S; Moreau JF; Taupin JL; Merville P; Déchanet-Merville J
J Am Soc Nephrol; 2014 Nov; 25(11):2471-82. PubMed ID: 24744438
[TBL] [Abstract][Full Text] [Related]
58. A high red blood cell distribution width predicts failure of arteriovenous fistula.
Bojakowski K; Dzabic M; Kurzejamska E; Styczynski G; Andziak P; Gaciong Z; Söderberg-Nauclér C; Religa P
PLoS One; 2012; 7(5):e36482. PubMed ID: 22574168
[TBL] [Abstract][Full Text] [Related]
59. Significance of cytomegalovirus infection in the failure of native arteriovenous fistula.
Dzabic M; Bojakowski K; Kurzejamska E; Styczynski G; Andziak P; Söderberg-Nauclér C; Religa P
Clin Microbiol Infect; 2012 Jan; 18(1):E5-7. PubMed ID: 22070535
[TBL] [Abstract][Full Text] [Related]
60. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
